Moderna repeatedly calls it a vaccine on its website. Was the "gene therapy" comment a Foxplanation perhaps? From a Facebook post?
Moderna Medical Services Hub provides resources and the latest information for Moderna COVID-19 Vaccine for Healthcare Providers in the USA
www.modernatx.com
You can read their own SEC Filings or listen to their Moderna Medical Officer explain it themselves:
“Moderna … describes its product not as a vaccine, but as ‘gene therapy technology’ in SEC filings. This is because neither Moderna nor Pfizer … make any claims about their products creating immunity or preventing transmission.” Additionally, Moderna’s SEC filings specifically state that “Currently, mRNA is considered a gene therapy product by the FDA,” as well.23
Here is the Moderna Cheif Medical Officer speaking at a Ted talk explaining mRNA gene therapy, he calls it "hacking the software of life"
You heard many times that the mRNA cerveza bug jabs are based on older cancer research, and that is correct, here it is, presented one of the current bosses at Moderna.
rumble.com
“In every cell there’s this thing called messenger RNA or mRNA for short, that transmits the critical information from the DNA in our genes to the protein, which is really the stuff we’re all made out of. This is the critical information that determines what the cell will do. So we think about it as an operating system
. …. So if you could actually change that, … if you could introduce a line of code, or change a line of code, it turns out, that has profound implications for everything, from the flu to cancer.”
Gene Therapy is mentioned 11 times in their SEC filing:
This is from the filing:
"Currently, mRNA is considered a gene therapy product by the FDA. Unlike certain gene therapies that irreversibly alter cell DNA and could act as a source of side effects, mRNA-based medicines are designed to not irreversibly change cell DNA; however, side effects observed in gene therapy could negatively impact the perception of mRNA medicines despite the differences in mechanism. In addition, because no product in which mRNA is the primary active ingredient has been approved, the regulatory pathway for approval is uncertain. The number and design of the clinical trials and preclinical studies required for the approval of these types of medicines have not been established, may be different from those required for gene therapy products, or may require safety testing like gene therapy products. Moreover, the length of time necessary to complete clinical trials and to submit an application for marketing approval for a final decision by a regulatory authority varies significantly from one pharmaceutical product to the next, and may be difficult to predict."